Also trades as: ONCS (NASDAQ) · $vol 1M
ONCSQ OTC
OncoSec Medical Incorporated
1W: +0.0%
1M: +0.0%
3M: +900.0%
YTD: -90.0%
1Y: -90.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$32M
+23.1% ▲
Capital Expenditures
$245K
+69.4% ▲
5Y CAGR: +62.6%
Free Cash Flow
-$32M
+24.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$34M
-231.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$39M | -$30M | -$42M | -$45M | -$34M |
| Depreciation & Amort. | $334K | $244K | $990K | $1M | $1M |
| Stock-Based Comp. | $0 | $3M | $4M | $5M | $2M |
| Change in Working Capital | $2M | -$4M | $4M | -$2M | -$1M |
| Other Non-Cash Items | $2M | $846K | $931K | $468K | $552K |
| Operating Cash Flow | -$23M | -$29M | -$33M | -$42M | -$32M |
| — Investing Activities — | |||||
| Capital Expenditures | -$65K | -$10K | $0 | -$800K | -$245K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$25M | $0 | $0 | $0 | $0 |
| Investment Sales | $2M | $23M | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$23M | $23M | $0 | -$800K | -$245K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$82K | $814K | -$619K | -$1M |
| Stock Repurchased | $0 | -$567 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$567 | $0 | $0 | $0 |
| Other Financing | $7M | -$616K | -$2M | $6M | -$41K |
| Financing Cash Flow | $39M | $27M | $28M | $68M | -$1M |
| Net Change in Cash | -$8M | $21M | -$5M | $26M | -$34M |
| Cash End of Period | $4M | $25M | $20M | $46M | $12M |
| Free Cash Flow | -$23M | -$29M | -$33M | -$43M | -$32M |